Purchase Order 75N95A18P00113
Award Date 7/9/18
Potential Completion Date 7/8/19
Potential Value $6.2K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $10,807.60 on August 22, 2018, for RNA probes and advanced cell diagnostics products. Performance is located in Newark, California. The order carries a firm fixed price, with an ultimate completion date of August 30, 2018. No set-aside category applies.</p>
- <p>The National Institute of Nursing Research awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $10,817.20 on August 28, 2018, with completion targeted for September 28, 2018. The order is for RNA detection technologies and related diagnostic products, with performance at the vendor's Newark, California facility. No small business set-aside applied.</p>
- <p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Advanced Cell Diagnostics, Inc. for $4,025.00 on July 29, 2017, for a hybridization system with batch slide system, with final completion by September 8, 2017. Performance occurs in Bethesda, Maryland. No set-aside applied to this firm fixed price acquisition.</p>
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $16,580 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNAScope under contract number 1187802. Advanced Cell Diagnostics, Inc. will deliver its cell diagnostics technology from its Newark, California location under the eight-month contract ending in March 2024. As part of the National Institutes of Health's medical research efforts, this contract provides RNAScope, a...
- Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services agency....
- <p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $13,814.40 on September 17, 2020, with completion targeted for November 26, 2020. The order carries firm fixed pricing with no small business set-aside. Performance occurs in Newark, California. The purchase order procures RNA detection technologies and related diagnostic products from Advanced Cell Diagnostics' RNAscope platform for cancer research support.</p>
- <p>The National Institute of Child Health and Human Development awarded a purchase order to Advanced Cell Diagnostics, Inc. for $10,000.00 on September 22, 2017, with completion by December 22, 2017. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for RNA detection technologies and related diagnostic products, consistent with Advanced Cell Diagnostics' RNAscope platform and specialized molecular pathology solutions supporting NIH research programs.</p>
- <p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $11,593.00 on May 28, 2021, for RNAscope technology and related reagents. Work is performed in Newark, California. The purchase order, issued under firm fixed-price terms with no set-aside, provides RNA detection and visualization capabilities for identifying TGF-beta isoforms in normal tissues and tumors using minimal sample material. The order closes on June 27, 2021.</p>
- <p>NIH Clinical Center awarded a purchase order to Advanced Cell Diagnostics, Inc. for $16,662.30 on May 17, 2018, to cover setup fees for new target probe RNAscopes and related accessories and shipping. Place of performance is Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of May 25, 2018. No set-aside was used.</p>
- Advanced Cell Diagnostics, Inc. (ACD) has been awarded a $26,945 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NIH NINDS) to provide RNAScope HiPlex Probes and Reagents. The solicitation sought these specific products from ACD to support research at NIH NINDS aimed at identifying and quantifying 40 RNA molecules in mouse brain tissue using ACD's proprietary RNAScope assay method. Delivery within one week of order...